Literature DB >> 32291396

Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis.

Álvaro López-Janeiro1, Carlos Padilla-Ansala2, Carlos E de Andrea3,4,5,6, David Hardisson2,7,8, Ignacio Melero5,6,9,10.   

Abstract

Macrophage polarization is relevant for tumor biology. M2 polarized macrophages favor tumor growth and survival, while M1 macrophages support tumor destruction and antigen presentation. Markers identifying M1/M2 polarization are a subject of debate. We conducted a systematic review and meta-analysis to investigate the association of proposed macrophage markers with prognosis across epithelial tumors and melanoma. The Medline search engine was used and 195 articles were recovered for full review. Only articles which measured markers using immunohistochemistry or immunofluorescence and had overall survival (OS) as the primary endpoint were included. One hundred and thirteen articles were finally accepted for analysis. CD68 was associated with worse survival across tumors (hazard ratio (HR) = 1.24, 95% CI = 1.11-1.37). Tumor anatomical location influenced this association. Colorectal tumors showed an inverse association between CD68 and OS in contrast to the rest of cancer types (HR = 0.56 vs. 1.34). The approach taken to measure CD68 had an impact on prognosis; when macrophages were measured at the tumor invasion front prognosis was more favorable than when they were measured intratumorally (HR = 0.94 vs. 1.4). CD163, CD204, and CD206 showed a robust association with worse OS (HR = 1.63, 1.95, 1.65, respectively). Tumors arising in the lung and the liver showed a weaker association between CD163 and OS as compared with other locations (β = -0.5401 for the lung and -0.5940 for the liver compared with other anatomical locations). The counting strategy also had an impact on CD163 association with OS, with hot-spot counting having higher HRs compared with averaging macrophage counts across spots or absolute cell counting (β = -0.4678). In conclusion, proposed M2 markers are associated with worse survival across epithelial tumors and melanoma. The anatomical origin of tumors influences this association. The compartment where the macrophages were scored and counting strategy influenced the association with OS of CD68 and CD163, respectively.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32291396     DOI: 10.1038/s41379-020-0534-z

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  16 in total

1.  Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy.

Authors:  Zheng Wang; Jingru Song; Nisma Lena Bahaji Azami; Mingyu Sun
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

2.  Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.

Authors:  Lin-Pei Wang; Jing Lin; Xiao-Qiu Ma; Dong-Yao Xu; Chun-Feng Shi; Wei Wang; Xiao-Jie Jiang
Journal:  J Exp Clin Cancer Res       Date:  2021-05-26

Review 3.  Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation.

Authors:  Melanie Vogl; Anna Rosenmayr; Tomas Bohanes; Axel Scheed; Milos Brndiar; Elisabeth Stubenberger; Bahil Ghanim
Journal:  Cancers (Basel)       Date:  2021-02-06       Impact factor: 6.639

Review 4.  Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician.

Authors:  Rebecca Adams; Bernhard Moser; Sophia N Karagiannis; Katie E Lacy
Journal:  Cancers (Basel)       Date:  2021-11-10       Impact factor: 6.575

Review 5.  Roles and mechanisms of exosomal non-coding RNAs in human health and diseases.

Authors:  Chen Li; Yu-Qing Ni; Hui Xu; Qun-Yan Xiang; Yan Zhao; Jun-Kun Zhan; Jie-Yu He; Shuang Li; You-Shuo Liu
Journal:  Signal Transduct Target Ther       Date:  2021-11-10

6.  Stage I-IV Colorectal Cancer Prognosis Can Be Predicted by Type and Number of Intratumoral Macrophages and CLEVER-1+ Vessel Density.

Authors:  Annika Ålgars; Lotta Kemppinen; Ruth Fair-Mäkelä; Harri Mustonen; Caj Haglund; Sirpa Jalkanen
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

7.  Tumor heterogeneity evaluated by computed tomography detects muscle-invasive upper tract urothelial carcinoma that is associated with inflammatory tumor microenvironment.

Authors:  Keisuke Goto; Yukiko Honda; Kenichiro Ikeda; Kenshiro Takemoto; Toru Higaki; Tetsutaro Hayashi; Kohei Kobatake; Yuko Nakamura; Yohei Sekino; Shogo Inoue; Kazuo Awai; Wataru Yasui; Jun Teishima
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

Review 8.  Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases.

Authors:  Maria K Skytthe; Jonas Heilskov Graversen; Søren K Moestrup
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

9.  A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma.

Authors:  Ya-Nan Xue; Yi-Nan Xue; Zheng-Cai Wang; Yong-Zhen Mo; Pin-Yan Wang; Wei-Qiang Tan
Journal:  Front Immunol       Date:  2020-10-19       Impact factor: 7.561

Review 10.  Macrophage Polarization in Cardiac Tissue Repair Following Myocardial Infarction.

Authors:  Yevgeniy Kim; Sanzhar Nurakhayev; Ayan Nurkesh; Zharylkasyn Zharkinbekov; Arman Saparov
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.